Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27


Combined evaluation of sexually transmitted infections in HIV-infected pregnant women and infant HIV transmission.

Adachi K, Xu J, Yeganeh N, Camarca M, Morgado MG, Watts DH, Mofenson LM, Veloso VG, Pilotto JH, Joao E, Gray G, Theron G, Santos B, Fonseca R, Kreitchmann R, Pinto J, Mussi-Pinhata MM, Ceriotto M, Machado DM, Bryson YJ, Grinsztejn B, Moye J, Klausner JD, Bristow CC, Dickover R, Mirochnick M, Nielsen-Saines K; NICHD HPTN 040 Study Team.

PLoS One. 2018 Jan 5;13(1):e0189851. doi: 10.1371/journal.pone.0189851. eCollection 2018.


Human Immunodeficiency Virus Antiretroviral Resistance and Transmission in Mother-Infant Pairs Enrolled in a Large Perinatal Study.

Yeganeh N, Kerin T, Ank B, Watts DH, Camarca M, Joao EC, Pilotto JH, Veloso VG, Bryson Y, Gray G, Theron G, Dickover R, Morgado MG, Santos B, Kreitchmann R, Mofenson L, Nielsen-Saines K.

Clin Infect Dis. 2018 May 17;66(11):1770-1777. doi: 10.1093/cid/cix1104.


Three postpartum antiretroviral regimens to prevent intrapartum HIV infection.

Nielsen-Saines K, Watts DH, Veloso VG, Bryson YJ, Joao EC, Pilotto JH, Gray G, Theron G, Santos B, Fonseca R, Kreitchmann R, Pinto J, Mussi-Pinhata MM, Ceriotto M, Machado D, Bethel J, Morgado MG, Dickover R, Camarca M, Mirochnick M, Siberry G, Grinsztejn B, Moreira RI, Bastos FI, Xu J, Moye J, Mofenson LM; NICHD HPTN 040/PACTG 1043 Protocol Team.

N Engl J Med. 2012 Jun 21;366(25):2368-79. doi: 10.1056/NEJMoa1108275.


Correlation of immune activation during late pregnancy and early postpartum with increases in plasma HIV RNA, CD4/CD8 T cells, and serum activation markers.

Truong HM, Sim MS, Dillon M, Uittenbogaart CH, Dickover R, Plaeger SF, Bryson YJ.

Clin Vaccine Immunol. 2010 Dec;17(12):2024-8. doi: 10.1128/CVI.00088-10. Epub 2010 Oct 27.


Optimization and limitations of use of cryopreserved peripheral blood mononuclear cells for functional and phenotypic T-cell characterization.

Weinberg A, Song LY, Wilkening C, Sevin A, Blais B, Louzao R, Stein D, Defechereux P, Durand D, Riedel E, Raftery N, Jesser R, Brown B, Keller MF, Dickover R, McFarland E, Fenton T; Pediatric ACTG Cryopreservation Working Group.

Clin Vaccine Immunol. 2009 Aug;16(8):1176-86. doi: 10.1128/CVI.00342-08. Epub 2009 Jun 10.


Continuous improvement in the immune system of HIV-infected children on prolonged antiretroviral therapy.

Weinberg A, Dickover R, Britto P, Hu C, Patterson-Bartlett J, Kraimer J, Gutzman H, Shearer WT, Rathore M, McKinney R; PACTG 1021 team.

AIDS. 2008 Nov 12;22(17):2267-77. doi: 10.1097/QAD.0b013e3283189bb3.


Long-term safety and efficacy of a once-daily regimen of emtricitabine, didanosine, and efavirenz in HIV-infected, therapy-naive children and adolescents: Pediatric AIDS Clinical Trials Group Protocol P1021.

McKinney RE Jr, Rodman J, Hu C, Britto P, Hughes M, Smith ME, Serchuck LK, Kraimer J, Ortiz AA, Flynn P, Yogev R, Spector S, Draper L, Tran P, Scites M, Dickover R, Weinberg A, Cunningham C, Abrams E, Blum MR, Chittick GE, Reynolds L, Rathore M; Pediatric AIDS Clinical Trials Group Protocol P1021 Study Team.

Pediatrics. 2007 Aug;120(2):e416-23. Epub 2007 Jul 23.


Multicenter evaluation of use of dried blood and plasma spot specimens in quantitative assays for human immunodeficiency virus RNA: measurement, precision, and RNA stability.

Brambilla D, Jennings C, Aldrovandi G, Bremer J, Comeau AM, Cassol SA, Dickover R, Jackson JB, Pitt J, Sullivan JL, Butcher A, Grosso L, Reichelderfer P, Fiscus SA.

J Clin Microbiol. 2003 May;41(5):1888-93.


Primary HIV infection of infants: the effects of somatic growth on lymphocyte and virus dynamics.

Krogstad P, Uittenbogaart CH, Dickover R, Bryson YJ, Plaeger S, Garfinkel A.

Clin Immunol. 1999 Jul;92(1):25-33.


Decreased CD8 cell-mediated viral suppression and other immunologic characteristics of women who transmit human immunodeficiency virus to their infants.

Plaeger S, Bermudez S, Mikyas Y, Harawa N, Dickover R, Mark D, Dillon M, Bryson YJ, Boyer PJ, Sinsheimer JS.

J Infect Dis. 1999 Jun;179(6):1388-94.


Early prognostic indicators in primary perinatal human immunodeficiency virus type 1 infection: importance of viral RNA and the timing of transmission on long-term outcome.

Dickover RE, Dillon M, Leung KM, Krogstad P, Plaeger S, Kwok S, Christopherson C, Deveikis A, Keller M, Stiehm ER, Bryson YJ.

J Infect Dis. 1998 Aug;178(2):375-87.


Primary human immunodeficiency virus type 1 infection during pregnancy associated with transmission of SI/MT-2 cell tropic virus and precipitous loss of CD4 cells in mother and infant.

von Seidlein L, Plaeger S, Dickover R, Krogstad P, Stiehm ER, Bryson Y.

Pediatr Infect Dis J. 1998 Jun;17(6):528-30. No abstract available.


Determinations of levels of human immunodeficiency virus type 1 RNA in plasma: reassessment of parameters affecting assay outcome. TUBE Meeting Workshop Attendees. Technology Utilization for HIV-1 Blood Evaluation and Standardization in Pediatrics.

Lew J, Reichelderfer P, Fowler M, Bremer J, Carrol R, Cassol S, Chernoff D, Coombs R, Cronin M, Dickover R, Fiscus S, Herman S, Jackson B, Kornegay J, Kovacs A, McIntosh K, Meyer W, Michael N, Mofenson L, Moye J, Quinn T, Robb M, Vahey M, Weiser B, Yeghiazarian T.

J Clin Microbiol. 1998 Jun;36(6):1471-9. Review. No abstract available.


Timing of lymphocyte activation in neonates infected with human immunodeficiency virus.

Gallagher K, Gorre M, Harawa N, Dillon M, Wafer D, Stiehm ER, Bryson Y, Song D, Dickover R, Plaeger S.

Clin Diagn Lab Immunol. 1997 Nov;4(6):742-7.


Human immunodeficiency virus type 1 genetic evolution in children with different rates of development of disease.

Ganeshan S, Dickover RE, Korber BT, Bryson YJ, Wolinsky SM.

J Virol. 1997 Jan;71(1):663-77.


Presence of human immunodeficiency virus (HIV) type 1 and HIV-1-specific antibodies in cervicovaginal secretions of infected mothers and in the gastric aspirates of their infants.

Nielsen K, Boyer P, Dillon M, Wafer D, Wei LS, Garratty E, Dickover RE, Bryson YJ.

J Infect Dis. 1996 Apr;173(4):1001-4.


Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load.

Dickover RE, Garratty EM, Herman SA, Sim MS, Plaeger S, Boyer PJ, Keller M, Deveikis A, Stiehm ER, Bryson YJ.

JAMA. 1996 Feb 28;275(8):599-605.


Clearance of HIV infection in a perinatally infected infant.

Bryson YJ, Pang S, Wei LS, Dickover R, Diagne A, Chen IS.

N Engl J Med. 1995 Mar 30;332(13):833-8.


Rapid increases in load of human immunodeficiency virus correlate with early disease progression and loss of CD4 cells in vertically infected infants.

Dickover RE, Dillon M, Gillette SG, Deveikis A, Keller M, Plaeger-Marshall S, Chen I, Diagne A, Stiehm ER, Bryson Y.

J Infect Dis. 1994 Nov;170(5):1279-84.


Decreases in unintegrated HIV DNA are associated with antiretroviral therapy in AIDS patients.

Dickover RE, Donovan RM, Goldstein E, Cohen SH, Bolton V, Huth RG, Liu GZ, Carlson JR.

J Acquir Immune Defic Syndr (1988). 1992;5(1):31-6.


HIV-1 proviral copy number in blood mononuclear cells from AIDS patients on zidovudine therapy.

Donovan RM, Dickover RE, Goldstein E, Huth RG, Carlson JR.

J Acquir Immune Defic Syndr (1988). 1991;4(8):766-9.


Vaccine protection of rhesus macaques against simian immunodeficiency virus infection.

Carlson JR, McGraw TP, Keddie E, Yee JL, Rosenthal A, Langlois AJ, Dickover R, Donovan R, Luciw PA, Jennings MB, et al.

AIDS Res Hum Retroviruses. 1990 Nov;6(11):1239-46.


Laboratory tests used in diagnosis and treatment of AIDS.

Goldstein E, Donovan RM, Dickover R.

Bratisl Lek Listy. 1990 Oct;91(10):747-52. Review. English, Slovak.


Quantitation of human immunodeficiency virus DNA by using the polymerase chain reaction.

Dickover RE, Donovan RM, Goldstein E, Dandekar S, Bush CE, Carlson JR.

J Clin Microbiol. 1990 Sep;28(9):2130-3.

Supplemental Content

Loading ...
Support Center